Healthcare


 Healthcare Company, PolyNovo Achieved Its First Million-Dollar Month

Healthcare Company, PolyNovo Achieved Its First Million-Dollar Month

May 03, 2019 04:08 PM AEST| By Team Kalkine Media

PolyNovo Limited (ASX: PNV) is an ASX listed healthcare company based in Melbourne, Australia. The company specialises in developing and manufacturing unique biodegradable polymers which are used in medical devices. Biodegradable Temporising Matrix (...

 ResMed Shares Skyrocketed On Solid Quarterly Results For Q3 FY19

ResMed Shares Skyrocketed On Solid Quarterly Results For Q3 FY19

May 03, 2019 02:06 PM AEST| By Team Kalkine Media

ResMed Inc.(NYSE: RMD, ASX: RMD) shares surged up over 9% in mid-day trade after the company announced 12% year-over-year growth in its revenue for the third quarter of Fiscal Year 2019. The stock is trading at $16.210, up 9.527%, as at 3 May 2019 (1...

 Anteo’s Battery & Life Sciences Division Making Excellent Progress With AnteoCoat™ And AnteoBind™

Anteo’s Battery & Life Sciences Division Making Excellent Progress With AnteoCoat™ And AnteoBind™

May 03, 2019 01:08 PM AEST| By Team Kalkine Media

Anteo Diagnostics Limited (ASX: ADO), a company from the Health Care sector that is into the business of Developing and commercializing medical products provided an update on commercial engagements in the Battery and Life Sciences division. The comp...

 MGC Pharmaceuticals Signed Two Agreements With Health House And Cannvalate

MGC Pharmaceuticals Signed Two Agreements With Health House And Cannvalate

May 03, 2019 01:04 PM AEST| By Team Kalkine Media

MGC Pharmaceuticals Ltd (ASX: MXC) is an ASX listed healthcare company based in Europe. The company has vast experience in the biopharma industry. Its primary business strategy is to develop and supply high-quality cannabinoid-based pharmaceuticals p...

 AdAlta Announces Completion of Confirmation Run for Manufacturing of AD-214

AdAlta Announces Completion of Confirmation Run for Manufacturing of AD-214

May 02, 2019 02:00 PM AEST| By Team Kalkine Media

Today, on 2nd May 2019, the biotechnology company AdAlta Limited (ASX: 1AD) announced that it is well on track with the development of AD-214 (a lead program) for Idiopathic Pulmonary Fibrosis, following the successful completion of a confirmation ru...

 BD1 Bags Patent For ‘Regulation Of BARD1 Expression By Non-Coding RNA’; Stock Surges 17%

BD1 Bags Patent For ‘Regulation Of BARD1 Expression By Non-Coding RNA’; Stock Surges 17%

May 01, 2019 08:46 PM AEST| By Team Kalkine Media

BARD1 Life Sciences Limited (ASX:BD1), a health sector company and biotechnology colonist, is focussed at commercialising and developing a blood test for the detection of lung cancer. This revolution that the company aims to process is technology cen...

 Orthocell’s Shares Rose On ASX Post Application To TGA For Approval Of CelGro®

Orthocell’s Shares Rose On ASX Post Application To TGA For Approval Of CelGro®

May 01, 2019 06:21 PM AEST| By Team Kalkine Media

Orthocell Limited (ASX: OCC) helps in the restoration of mobility and formation of soft tissue. The company also focuses on providing different new approaches to the formation of tendon, cartilage and the repair of soft tissue injuries. The company...

 Zelda Therapeutics Unveils Latest Quarterly Results

Zelda Therapeutics Unveils Latest Quarterly Results

May 01, 2019 01:49 PM AEST| By Team Kalkine Media

Zelda Therapeutics Limited (ASX: ZLD) is an ASX listed pharmaceutical company having an interest in the cannabis market and is based in Australia. It aims to treat a variety of medical conditions using cannabinoid-based formulations. Currently, the c...

 EBOS Announces ~NZ$150 Million Equity Placement To Provide Further Capacity For Growth

EBOS Announces ~NZ$150 Million Equity Placement To Provide Further Capacity For Growth

April 30, 2019 08:17 PM AEST| By Team Kalkine Media

Today, on 30th April 2019, EBOS Group Limited (ASX: EBO) updated to the market that its securities have been placed in a trading halt at the request of the company due to pending it releasing an announcement. At the time of such development, the stoc...

 ImpediMed Signed $1.3 Million in Total Contract Value for SOZO® During Q3 FY19

ImpediMed Signed $1.3 Million in Total Contract Value for SOZO® During Q3 FY19

April 30, 2019 06:41 PM AEST| By Team Kalkine Media

ImpediMed Limited (ASX: IPD) works under the health care sector and is into the development and sale of the ImpediMed medical devices internationally. The company?s headquarter is situated in Brisbane. It has operations in the US and Europe as well.....

 A Quick Review of Nanollose and Estrella March Quarter Reports

A Quick Review of Nanollose and Estrella March Quarter Reports

April 30, 2019 12:44 PM AEST| By Team Kalkine Media

Nanollose Limited and Estrella Resources Limited released their quarterly reports on 29 April 2019 for the quarter ending 31 March 2019. Nanollose Limited An innovative firm based in Australia, Nanollose Limited (ASX: NC6) is engaged in producing ?...

 Cellmid Released Q3 FY2019 Cash Flow Report, Company On Track For FY2020 Profitability.

Cellmid Released Q3 FY2019 Cash Flow Report, Company On Track For FY2020 Profitability.

April 29, 2019 09:45 PM AEST| By Team Kalkine Media

?Cellmid Limited (ASX: CDY) is an Australian life sciences accelerator from the health care sector, with lead programs in various disease indications.? On 29th April 2019, Cellmid Limited released its quarterly cash flow report for the quarter ended...

 Healthia Announced The Appointment Of Its New CEO; Stock Zoomed Up

Healthia Announced The Appointment Of Its New CEO; Stock Zoomed Up

April 29, 2019 08:54 PM AEST| By Team Kalkine Media

Healthia Limited (ASX: HLA) is an ASX listed healthcare company based in Queensland, Australia. The company aims to deliver world-class health services to enrich the lives of people. The company has a portfolio of a few healthcare companies including...

 HeraMED Seeks Approval for HeraBEAT- Submitted 510K Application To FDA

HeraMED Seeks Approval for HeraBEAT- Submitted 510K Application To FDA

April 29, 2019 06:02 PM AEST| By Team Kalkine Media

HeraMED Limited (ASX: HMD) is a medical technology company. The company offers smart pregnancy monitoring solutions for professional and home use. HeraMED provides peace of mind to expecting parents by solving problems associated with the reliability...

 Rhinomed Released Its March 2019 Quarterly Report

Rhinomed Released Its March 2019 Quarterly Report

April 29, 2019 05:21 PM AEST| By Team Kalkine Media

Rhinomed Limited (ASX: RNO) is an ASX listed healthcare company based in Australia. The company is primarily focused on healthcare technology and aims to provide people with better devices for looking after their health. Some of the popular products...

 Will This Healthcare Player Sustain Its Recent Uptrend – ASX: GMV

Will This Healthcare Player Sustain Its Recent Uptrend – ASX: GMV

April 27, 2019 09:15 AM AEST| By Team Kalkine Media

G Medical Innovations Holdings Limited (ASX: GMV) is gen-next mobile health, as well as e-health company. It is involved with the development and marketing of clinical and customer medical-grade health monitoring solutions. GMV also provide end-to-en...

 Large-Cap Healthcare Players – ANN, SHL, HSO

Large-Cap Healthcare Players – ANN, SHL, HSO

April 27, 2019 09:00 AM AEST| By Team Kalkine Media

Ansell Limited (ASX: ANN) Ansell Limited (ASX: ANN) recently published a release containing important information with respect to the change of interests of the substantial holder. The release stated that BlackRock Group, a substantial holder of the...

 All That Investors Need To Know - ASX: PAR

All That Investors Need To Know - ASX: PAR

April 27, 2019 08:15 AM AEST| By Team Kalkine Media

Paradigm Biopharmaceuticals Limited (ASX: PAR) announced that it has completed the institutional component of the entitlement offer announced recently, which is fully underwritten and non-renounceable in nature, raising approximately $9.8 million. T...

 Stocks In Biotech & Pharma Space - NXS, NOX, PAR

Stocks In Biotech & Pharma Space - NXS, NOX, PAR

April 27, 2019 08:00 AM AEST| By Team Kalkine Media

The below-mentioned stocks are operating under Biotech and Pharma space. These stocks have made significant operational progress in the recent past. Let's take a closer look at each. Next Science Limited (ASX: NXS) Australian medical technology c...

 Telix Publishes Fractionated Therapy Data For 177Lu-Huj591 In Peer-Reviewed Journal Cancer

Telix Publishes Fractionated Therapy Data For 177Lu-Huj591 In Peer-Reviewed Journal Cancer

April 26, 2019 10:13 PM AEST| By Team Kalkine Media

Telix Pharmaceuticals Limited (ASX: TLX), a company from the health care sector, is engaged in the development and commercialization of molecularly targeted radiation products for the treatment of cancer. On 26 April 2019, Telix Pharmaceuticals Limi...

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.